Skip to main content
. Author manuscript; available in PMC: 2010 Mar 11.
Published in final edited form as: J Rheumatol. 2009 Oct 15;36(11):2462–2469. doi: 10.3899/jrheum.090188

Table 4.

Risk of Cardiovascular Outcomes associated with Autoantibodies in Men versus Women

Autoantibody Outcome Events Hazard ratio (95% CI)*

Men Women Men Women
RF MI, HF or PVD** 313 558 1.46 (1.04, 2.04) 1.14 (0.88, 1.46)
Death 382 616 1.31 (1.00, 1.71) 1.56 (1.27, 1.92)
ANA MI, HF or PVD** 310 580 1.40 (1.07, 1.82) 1.22 (1.02, 1.45)
Death 475 667 1.17 (0.95, 1.44) 1.20 (1.02, 1.41)
*

Adjusted for age, calendar year, comorbidity, and presence of rheumatic disease

**

Defined as the first occurrence of any of the 3 events

RF = rheumatoid factor; ANA = antinuclear antibody; MI = myocardial infarction; HF = heart failure; PVD = peripheral vascular disease; HR = hazard ratio; CI = confidence interval; comorbidity = chronic disease comorbidities (9)